Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

Delavirdine Mesylate

Known as: Delavirdine Mesylate [Chemical/Ingredient], Mesylate, Delavirdine 
A mesylate salt form of delavirdine, a synthetic, non-nucleoside reverse transcriptase inhibitor. In combination with other anti-retroviral drugs… Expand
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2002
Review
2002
Rifampin is a potent inducer of cytochrome P-450 oxidative enzymes. A few examples of well-documented clinically significant… Expand
  • table 1
  • table 2
  • table 3
  • table 4
Is this relevant?
1999
1999
To evaluate the antiretroviral activity of delavirdine mesylate, a nonnucleoside reverse transcriptase inhibitor of HIV-1, we… Expand
Is this relevant?
1998
1998
Administration of delavirdine, an HIV-1 reverse transcriptase inhibitor, to rats or monkeys resulted in apparent loss of hepatic… Expand
  • figure 1
  • table 1
  • table 2
  • figure 2
  • figure 3
Is this relevant?
1997
1997
OBJECTIVE To study the effect of rifampin (INN, rifampicin), a potent inducer of cytochrome P450, on the steady-state… Expand
Is this relevant?
1997
1997
The oxidative metabolism of delavirdine, a non-nucleoside inhibitor of HIV-1 reverse transcriptase, is mediated in part by… Expand
Is this relevant?
1997
1997
Delavirdine is a nonnucleoside reverse transcriptase inhibitor with in vitro activity against human immunodeficiency virus type 1… Expand
  • table 1
  • table 2
  • table 3
  • figure 1
  • figure 2
Is this relevant?
1997
1997
OBJECTIVE The steady-state kinetics of delavirdine and desisopropyldelavirdine were evaluated in human immunodeficiency virus… Expand
  • table I
  • figure 1
  • figure 2
  • table II
  • table III
Is this relevant?
1997
1997
Delavirdine mesylate (U-90152T) is a highly specific nonnucleoside reverse transcriptase inhibitor currently under development… Expand
  • figure 2
  • figure 3
  • table 1
  • table 2
  • figure 4
Is this relevant?
Review
1996
Review
1996
In summary, DLV has been well-tolerated in > 1,000 HIV-1 infected patients. Skin rash is the most prevalent medical event… Expand
Is this relevant?
1996
1996
Delavirdine mesylate (DLV) is a potent nonnucleoside reverse transcriptase inhibitor with activity specific for human… Expand
Is this relevant?